Coronavirus Vaccine Landscape in Pakistan: Where Do We Stand?

Abstract

Developing countries like Pakistan have had an opportunity to make the ongoing pandemic count. The country has already been at the forefront of several natural disasters and conflicts in the past decades. In less than one year, the recruitment of over 25000 volunteers nationwide shows the potential and local expertise available to undertake phase III trials for experimental vaccines. It augurs well for the local population to now be able to partake in high-quality multicountry research given the health emergency created by SARS-CoV-2 since March 2020. Academic institutions have paved the way for the biopharmaceutical sector to capitalize on.